Images from the Radiological Society of North America (RSNA) 2022 annual meeting Nov. 27- Dec. 1 in Chicago. The gallery includes new technologies and a look at sights around the world's largest radiology conference. 

“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022. 

New findings to be presented at RSNA confirm that lung cancer is highly curable as long as it’s diagnosed early, as is often the case with low-dose CT screenings.

Radiologists from across Canada descended on Parliament Hill in Ottawa earlier this month to voice pressing concerns on behalf of medical-imaging patients and professionals.

More than 16% of eligible individuals get screened for lung cancer in Massachusetts. Only 1% do so in California. The national average is unfortunately closer to the latter extreme, at 5.8%.

RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.